Ratings by Wolfe Research (Jacob Lacks)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/14/2025 | RXO, Inc. | RXO | Upgrade | Peerperform (Underperform) |
10.63 (13.74) |
29.26% | Details | |
| 11/7/2025 | Matson, Inc. | MATX | Upgrade | Outperform (Peerperform) |
109.45 (152.99) |
39.78% | Details | |
| 8/8/2025 | RXO, Inc. | RXO | Maintain | Underperform (N/A) |
|
Details | ||
| 11/18/2024 | Matson, Inc. | MATX | Downgrade | Peerperform (Outperform) |
160.65 (109.45) |
-31.87% | Details | |
| 2/9/2024 | RXO, Inc. | RXO | Maintain | Underperform (N/A) |
|
Details | ||
| 8/3/2023 | RXO, Inc. | RXO | Maintain | Underperform (N/A) |
|
Details | ||
| 7/12/2023 | RXO, Inc. | RXO | Downgrade | Underperform (Peerperform) |
21.96 (10.63) |
-51.59% | Details | |
| 11/10/2022 | RXO, Inc. | RXO | New Coverage | Peerperform (N/A) |
18.10 (13.74) |
-24.09% | Details |
